Skip to main content

Heat Biologics, Inc. (HTBX)

NASDAQ: HTBX · IEX Real-Time Price · USD
5.49
+0.13 (2.43%)
After-hours:Oct 25, 2021 7:30 PM EDT
5.36
-0.07 (-1.29%)
At close: Oct 25, 4:00 PM

Total Valuation

Heat Biologics has a market cap or net worth of $138.42 million. The enterprise value is $17.39 million.

Market Cap138.42M
Enterprise Value17.39M

Important Dates

The next earnings date is Monday, November 8, 2021 before market open.

Estimated Earnings DateNov 8, 2021
Ex-Dividend Daten/a

Share Statistics

Heat Biologics has 25.14 million shares outstanding. The number of shares has increased by 100.11% in one year.

Shares Outstanding25.14M
Shares Change (YoY)+100.11%
Shares Change (QoQ)+3.87%
Owned by Insiders (%)4.28%
Owned by Institutions (%)12.20%
Float24.31M

Valuation Ratios

PE Ration/a
Forward PEn/a
PS Ratio56.47
PB Ratio1.05
P/FCF Ration/a
PEG Ration/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is n/a, with a EV/FCF ratio of n/a.

EV / Earningsn/a
EV / Sales7.10
EV / EBITDAn/a
EV / EBITn/a
EV / FCFn/a

Financial Position

The company has a current ratio of 37.22, with a Debt / Equity ratio of 0.01.

Current Ratio37.22
Quick Ratio36.74
Debt / Equity0.01
Debt / EBITDA-0.06
Debt / FCF-0.06

Financial Efficiency

Return on Equity (ROE)-23.20%
Return on Assets (ROA)-21.90%
Return on Capital (ROIC)-27.00%
Revenue Per Employee$62,848
Profits Per Employee-$753,297
Employee Count39
Asset Turnover0.02
Inventory Turnovern/a

Taxes

Income Taxn/a
Effective Tax Raten/a

Stock Price Statistics

The stock price has decreased by -34.81% in the last 52 weeks. The beta is 0.51, so Heat Biologics's price volatility has been lower than the market average.

Beta (1Y)0.51
52-Week Price Change-34.81%
50-Day Moving Average5.99
200-Day Moving Average6.49
Average Volume (30 Days)206,983

Short Selling Information

Short Interest2.14M
Short % of Shares Out8.49%
Short % of Float8.78%
Short Ratio (days to cover)6.39

Income Statement

In the last 12 months, Heat Biologics had revenue of $2.45 million and -$29.38 million in losses. Earnings per share was -$1.27.

Revenue2.45M
Gross Profit2.45M
Operating Income-30.02M
Net Income-29.38M
EBITDA-28.87M
EBIT-29.38M
Earnings Per Share (EPS)-$1.27
Full Income Statement

Balance Sheet

The company has $122.68 million in cash and $1.66 million in debt, giving a net cash position of $121.02 million or $4.81 per share.

Cash & Cash Equivalents122.68M
Total Debt1.66M
Net Cash121.02M
Net Cash Per Share$4.81
Book Value131.39M
Book Value Per Share5.23
Working Capital121.41M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$22.95 million and capital expenditures -$3.77 million, giving a free cash flow of -$26.72 million.

Operating Cash Flow-22.95M
Capital Expenditures-3.77M
Free Cash Flow-26.72M
FCF Per Share-$1.06
Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -1,224.78% and -1,198.61%.

Gross Margin100.00%
Operating Margin-1,224.78%
Pretax Marginn/a
Profit Margin-1,198.61%
EBITDA Margin-1,177.92%
EBIT Margin-1,198.61%
FCF Margin-1,090.24%

Dividends & Yields

Heat Biologics does not appear to pay any dividends at this time.

Dividend Per Sharen/a
Dividend Yieldn/a
Earnings Yield-21.22%
FCF Yield-19.31%
Dividend Growth (YoY)n/a
Payout Ration/a

Stock Splits

The last stock split was on December 11, 2020. It was a reverse split with a ratio of 1:7.

Last Split DateDec 11, 2020
Split TypeReverse
Split Ratio1:7